Codex DNA Inc. (DNAY)
NASDAQ: DNAY
· Real-Time Price · USD
1.30
0.10 (8.33%)
At close: Jan 04, 2023, 6:00 AM
Codex DNA Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2024 | Q2 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 3.72M | 6.4M | 17.39M | 46.61M | 23.36M | 30.42M | 24.74M | 22.28M | 31.36M | 82.81M | 109.8M | 123.77M | 17.83M |
Short-Term Investments | 794K | 3.82M | 24.06M | 747K | 8.71M | 13.16M | 25.01M | 39.61M | 45.41M | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 491K | 2.34M | 852K | 973K | 981K | 981K | 915K | 734K | 656K | 609K | 149K | 81K | 81K |
Receivables | 1.26M | 1.33M | 5.36M | 8.24M | 5.83M | 5.85M | 5.66M | 4.88M | 4.56M | 3.67M | 2.94M | 1.92M | 1.72M |
Inventory | 1.1M | 1.36M | 4.27M | 3.86M | 2.29M | 2.2M | 2.19M | 1.78M | 2.54M | 2.37M | 1.67M | 1.05M | 723K |
Other Current Assets | 1.25M | 2.25M | 1.63M | 2.09M | 2.74M | 3.46M | 4.57M | 3.48M | 4.01M | 4.34M | 2.98M | 554K | 1.62M |
Total Current Assets | 8.12M | 15.16M | 52.71M | 61.54M | 42.94M | 55.09M | 62.19M | 72.03M | 87.88M | 93.18M | 117.39M | 127.3M | 21.9M |
Property-Plant & Equipment | 11.99M | 30.98M | 35.08M | 35.5M | 28.6M | 8.52M | 8.14M | 8.05M | 5.99M | 5.74M | 1.47M | 3.44M | 3.63M |
Goodwill & Intangibles | 4.13M | 4.25M | 16.38M | 16.51M | 16.64M | 16.77M | 16.9M | 16.47M | 16.61M | 16.73M | 5.49M | 5.6M | 5.71M |
Total Long-Term Assets | 16.62M | 37.57M | 52.32M | 52.98M | 46.22M | 26.27M | 25.96M | 25.26M | 23.26M | 23.07M | 7.1M | 9.12M | 9.42M |
Total Assets | 24.74M | 52.73M | 105.03M | 114.53M | 89.16M | 81.36M | 88.14M | 97.28M | 111.13M | 116.26M | 124.49M | 136.42M | 31.32M |
Account Payables | 1.49M | 1.54M | 2.4M | 1.43M | 2.44M | 1.29M | 1.62M | 3.87M | 3.85M | 2.5M | 2.21M | 2.06M | 1.21M |
Deferred Revenue | 263K | 380K | 1.18M | 2.17M | 2.98M | 3.96M | 4.19M | 4.09M | 4.07M | 205K | 307K | 417K | 553K |
Short-Term Debt | 2.21M | 1.79M | 16.95M | 1.55M | 774K | 637K | 733K | 4.84M | 3.32M | 1.84M | 1.94M | 822K | 797K |
Other Current Liabilities | 2.67M | 4.3M | 4.89M | 5.23M | 5.05M | 7.61M | 6.27M | 5.45M | 4.78M | 5.19M | 3.41M | 3.52M | 3.03M |
Total Current Liabilities | 6.63M | 8.01M | 25.42M | 10.39M | 11.24M | 13.5M | 12.81M | 18.24M | 16.02M | 9.73M | 7.86M | 6.82M | 5.58M |
Long-Term Debt | 14.09M | 33.76M | 32.96M | 47.71M | 40.94M | 20.79M | 20.64M | 11.96M | 13.73M | 4.46M | 13.66M | 16.92M | 17.02M |
Other Long-Term Liabilities | 149K | 910K | 41K | 208K | 227K | 367K | 396K | 112K | 85K | 11.13M | 119K | 134K | 41.32M |
Total Long-Term Liabilities | 14.23M | 34.77M | 33.12M | 48.07M | 41.3M | 21.3M | 22.03M | 14.32M | 17.01M | 15.74M | 13.87M | 17.16M | 58.44M |
Total Liabilities | 20.86M | 42.78M | 58.54M | 58.46M | 52.54M | 34.8M | 34.83M | 32.56M | 33.03M | 25.47M | 21.73M | 23.98M | 64.02M |
Total Debt | 16.29M | 35.55M | 49.92M | 49.26M | 41.72M | 21.43M | 21.38M | 16.8M | 17.05M | 6.3M | 15.6M | 17.74M | 17.82M |
Common Stock | n/a | n/a | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 2K |
Retained Earnings | -189.33M | -182.69M | -143.78M | -133.15M | -124.86M | -113.74M | -105.61M | -93.3M | -78.46M | -65.27M | -52.78M | -42.95M | -33.75M |
Comprehensive Income | -5K | -9K | -15K | -28.15M | 2K | n/a | -20K | -34K | -16K | n/a | -124.49M | -136.42M | n/a |
Shareholders Equity | -27.22M | -20.54M | 17.77M | 27.92M | 36.62M | 46.56M | -105.61M | 64.72M | 78.1M | 90.78M | 102.76M | 112.44M | -32.7M |
Total Investments | n/a | n/a | 24.06M | 747K | 8.71M | 13.16M | 25.01M | 39.61M | 45.41M | n/a | n/a | n/a | n/a |